We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Shared Decision Making for Schizophrenia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00220870
First Posted: September 22, 2005
Last Update Posted: April 8, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Technische Universität München
  Purpose
The impact of a decision aid for inpatients with schizophrenia on perceived involvement and compliance is studied in comparison with routine care.

Condition Intervention
Schizophrenia Behavioral: Decision aid

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Shared Decision Making in the Therapy of Schizophrenia

Resource links provided by NLM:


Further study details as provided by Technische Universität München:

Primary Outcome Measures:
  • Patients' compliance

Secondary Outcome Measures:
  • perceived involvement in medical decisions
  • rehospitalizations
  • QoL

Study Start Date: January 2003
Estimated Study Completion Date: August 2005
Detailed Description:
to follow
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • schizophrenia (ICD10)
  • age 18 - 65 years
  • inpatients

Exclusion Criteria:

  • mental retardation
  • no informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00220870


Locations
Germany
Psychiatric Department, TU München
München, Germany, 81675
Sponsors and Collaborators
Technische Universität München
Investigators
Study Chair: Werner Kissling, MD TU München, Psychiatric Department
  More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00220870     History of Changes
Other Study ID Numbers: 217-43794-5/9
First Submitted: September 15, 2005
First Posted: September 22, 2005
Last Update Posted: April 8, 2010
Last Verified: April 2010

Keywords provided by Technische Universität München:
schizophrenia
shared decision making
compliance
maintenance therapy

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders